We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Nova Biomedical Showcases Advanced Point-of-Care Capillary Blood Analyzers at MEDLAB Middle East 2021

By LabMedica International staff writers
Posted on 22 Jun 2021
Print article
Image: Nova Point-of-Care Capillary Blood Analyzers (Photo courtesy of Nova Biomedical)
Image: Nova Point-of-Care Capillary Blood Analyzers (Photo courtesy of Nova Biomedical)
Nova Biomedical (Waltham, MA, USA) showcased its advanced point-of-care (POC) capillary blood analyzers at MEDLAB Middle East 2021, alongside other products such as POC meters for glucose testing, renal function monitoring and lactate testing.

At this year’s MEDLAB Middle East, Nova exhibited the StatStrip Glucose, which is the only glucose meter cleared by the US FDA for use with critically ill patients, that achieves superior accuracy with no clinical interferences. StatStrip is designed specifically to measure and correct for clinical interferences that can be present in critically ill patients. Nova also showcased the Stat Profile Prime Plus that combines blood gases, electrolytes, metabolites, CO-Oximetry, and 34 calculated results in a simple, compact critical care blood gas analyzer. Prime Plus combines maintenance-free, component cartridge technology for sensors and reagents with patented, new, maintenance-free, and non-lysing whole blood CO-Oximetry technology.

In addition, Nova showcased Allegro, a compact, point-of-care (POC) analyzer that features a clinically important menu of 10 measured and individually selectable tests, plus seven calculated tests. All tests are measured with disposable, ready-to-use cartridges or test strips, and are easily performed by non-technical personnel. Allegro uses a very small capillary blood drop for all blood tests, which eliminates the need for venipunctures or a trained phlebotomist. With cartridge test times of six to nine minutes and the ability to measure two cartridges simultaneously, Allegro provides rapid results.

Also on display at the event was the EMS Stat, a portable system for A&E use for GLU, KET, LAC, Hb, and HCT testing. Stat EMS can measure lactate, hematocrit, hemoglobin, glucose, and ketone from a capillary blood drop. Results are available in seconds by using single-use biosensors and portable meters. Stat EMS offers simple, fast, and accurate testing in the field. These tests can also help determine the appropriate transport site for patients with trauma, sepsis, or other specialized needs.

Related Links:
Nova Biomedical

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The ePlex system has been rebranded as the cobas eplex system (Photo courtesy of Roche)

Enhanced Rapid Syndromic Molecular Diagnostic Solution Detects Broad Range of Infectious Diseases

GenMark Diagnostics (Carlsbad, CA, USA), a member of the Roche Group (Basel, Switzerland), has rebranded its ePlex® system as the cobas eplex system. This rebranding under the globally renowned cobas name... Read more

Pathology

view channel
Image: The revolutionary autonomous blood draw technology is witnessing growing demands (Photo courtesy of Vitestro)

Robotic Blood Drawing Device to Revolutionize Sample Collection for Diagnostic Testing

Blood drawing is performed billions of times each year worldwide, playing a critical role in diagnostic procedures. Despite its importance, clinical laboratories are dealing with significant staff shortages,... Read more